Arlington Partners LLC Bristol Myers Squibb CO Transaction History

Arlington Partners LLC

$241 Million
Q3 2024

A detailed history of Arlington Partners LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Arlington Partners LLC holds 90,797 shares of BMY stock, worth $5.35 Million. This represents 1.95% of its overall portfolio holdings.

Number of Shares

90,797

Previous 78,306 15.95%

Holding current value

$5.35 Million

Previous $3.25 Million 44.46%

% of portfolio

1.95%

Previous 1.72%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 21, 2024	BUY	$39.66 - $51.75 $495,393 - $646,409	12,491 Added 15.95%	90,797 $4.7 Million
Q2 2024 Aug 01, 2024	BUY	$40.25 - $52.99 $634,863 - $835,811	15,773 Added 25.22%	78,306 $3.25 Million
Q1 2024 Apr 16, 2024	BUY	$47.98 - $54.4 $2.91 Million - $3.29 Million	60,558 Added 3066.23%	62,533 $3.39 Million
Q4 2023 Jan 24, 2024	BUY	$48.48 - $57.85 $95,748 - $114,253	1,975 New	1,975 $101,000
Q2 2023 Jul 26, 2023	SELL	$63.71 - $70.74 $11,595 - $12,874	-182 Reduced 9.71%	1,692 $108,000
Q1 2023 Apr 26, 2023	SELL	$65.71 - $74.53 $20,830 - $23,626	-317 Reduced 14.47%	1,874 $129,000
Q4 2022 Jan 19, 2023	BUY	$68.48 - $81.09 $27,665 - $32,760	404 Added 22.61%	2,191 $158,000
Q3 2022 Oct 28, 2022	SELL	$0.13 - $76.84 $22 - $13,216	-172 Reduced 8.78%	1,787 $127,000
Q2 2022 Jul 25, 2022	BUY	$72.62 - $79.98 $46,694 - $51,427	643 Added 48.86%	1,959 $151,000
Q1 2022 Apr 14, 2022	BUY	$61.48 - $73.72 $4,549 - $5,455	74 Added 5.96%	1,316 $96,000
Q4 2021 Jan 18, 2022	SELL	$53.63 - $62.52 $54,648 - $63,707	-1,019 Reduced 45.07%	1,242 $77,000
Q3 2021 Oct 15, 2021	BUY	$59.17 - $69.31 $93,429 - $109,440	1,579 Added 231.52%	2,261 $134,000
Q2 2020 Jul 13, 2020	BUY	$54.82 - $64.09 $32,508 - $38,005	593 Added 666.29%	682 $40,000
Q1 2020 Apr 13, 2020	SELL	$46.4 - $67.43 $18,560 - $26,972	-400 Reduced 81.8%	89 $5,000
Q4 2019 Jan 16, 2020	BUY	$49.21 - $64.19 $4,379 - $5,712	89 Added 22.25%	489 $31,000
Q2 2019 Jul 10, 2019	SELL	$44.62 - $49.34 $52,160 - $57,678	-1,169 Reduced 74.51%	400 $18,000
Q1 2019 Apr 05, 2019	BUY	$45.12 - $53.8 $7,625 - $9,092	169 Added 12.07%	1,569 $75,000
Q4 2018 Jan 10, 2019	BUY	$48.76 - $63.23 $19,504 - $25,292	400 Added 40.0%	1,400 $73,000
Q3 2018 Oct 23, 2018	BUY	$55.19 - $62.25 $55,190 - $62,250	1,000 New	1,000 $62,000

Others Institutions Holding BMY

# of Institutions

2,533

Shares Held

1.47B

Call Options Held

31.6M

Put Options Held

35M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $125B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Arlington Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Arlington Partners LLC with notifications on news.

Account

Arlington Partners LLC Bristol Myers Squibb CO Transaction History